2022 Taiwan lipid guidelines for primary prevention

the expert committee for the Taiwan Lipid Guidelines for Primary Prevention

doi:10.1016/j.jfma.2022.05.010

2022 Taiwan lipid guidelines for primary prevention

the expert committee for the Taiwan Lipid Guidelines for Primary Prevention

研究成果: Article › 同行評審

20 引文斯高帕斯（Scopus）

摘要

Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.

原文	English
頁（從 - 到）	2393-2407
頁數	15
期刊	Journal of the Formosan Medical Association
卷	121
發行號	12
DOIs	https://doi.org/10.1016/j.jfma.2022.05.010
出版狀態	Published - 12月 2022

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.jfma.2022.05.010

其它文件與鏈接

Link to publication in Scopus

引用此

@article{6b43d16341b746ae9ef777cde054f94b,

title = "2022 Taiwan lipid guidelines for primary prevention",

abstract = "Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.",

keywords = "Atherosclerosis, Cholesterol, Taiwan",

author = "{the expert committee for the Taiwan Lipid Guidelines for Primary Prevention} and Huang, {Po Hsun} and Lu, {Ya Wen} and Tsai, {Yi Lin} and Wu, {Yen Wen} and Li, {Hung Yuan} and Chang, {Hsin Yun} and Wu, {Chih Hsing} and Yang, {Chih Yu} and Tarng, {Der Cherng} and Huang, {Chin Chou} and Ho, {Li Ting} and Lin, {Chao Feng} and Chien, {Shih Chieh} and Wu, {Yih Jer} and Yeh, {Hung I.} and Pan, {Wen Harn} and Li, {Yi Heng}",

note = "Publisher Copyright: {\textcopyright} 2022 Formosan Medical Association",

year = "2022",

month = dec,

doi = "10.1016/j.jfma.2022.05.010",

language = "English",

volume = "121",

pages = "2393--2407",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier B.V.",

number = "12",

}

TY - JOUR

T1 - 2022 Taiwan lipid guidelines for primary prevention

AU - the expert committee for the Taiwan Lipid Guidelines for Primary Prevention

AU - Huang, Po Hsun

AU - Lu, Ya Wen

AU - Tsai, Yi Lin

AU - Wu, Yen Wen

AU - Li, Hung Yuan

AU - Chang, Hsin Yun

AU - Wu, Chih Hsing

AU - Yang, Chih Yu

AU - Tarng, Der Cherng

AU - Huang, Chin Chou

AU - Ho, Li Ting

AU - Lin, Chao Feng

AU - Chien, Shih Chieh

AU - Wu, Yih Jer

AU - Yeh, Hung I.

AU - Pan, Wen Harn

AU - Li, Yi Heng

PY - 2022/12

Y1 - 2022/12

N2 - Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.

AB - Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD later in life is important. The Taiwan Society of Lipids and Atherosclerosis in association with the other seven societies developed this new lipid guideline focusing on subjects without clinically significant ASCVD. In this guideline for primary prevention, the recommended LDL-C target is based on risk stratification. A healthy lifestyle with recommendations for foods, dietary supplements and alcohol drinking are described. The pharmacological therapies for LDL-C reduction are recommended. The aim of this guideline is to decrease the risk of ASCVD through adequate control of dyslipidemia in Taiwan.

KW - Atherosclerosis

KW - Cholesterol

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=85131438343&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2022.05.010

DO - 10.1016/j.jfma.2022.05.010

M3 - Article

C2 - 35715290

AN - SCOPUS:85131438343

SN - 0929-6646

VL - 121

SP - 2393

EP - 2407

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 12

ER -

2022 Taiwan lipid guidelines for primary prevention

摘要

UN SDG

存取文件

其它文件與鏈接

指紋

引用此